[go: up one dir, main page]

AR102865A1 - Parejas de fusión para la producción de péptidos - Google Patents

Parejas de fusión para la producción de péptidos

Info

Publication number
AR102865A1
AR102865A1 ARP150103916A ARP150103916A AR102865A1 AR 102865 A1 AR102865 A1 AR 102865A1 AR P150103916 A ARP150103916 A AR P150103916A AR P150103916 A ARP150103916 A AR P150103916A AR 102865 A1 AR102865 A1 AR 102865A1
Authority
AR
Argentina
Prior art keywords
polypeptide
production
interest
fusion partner
peptides
Prior art date
Application number
ARP150103916A
Other languages
English (en)
Inventor
Jin Hongfan
R Bruck Torben
Chapman Adam
M Retallack Diane
Original Assignee
Pfenex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfenex Inc filed Critical Pfenex Inc
Publication of AR102865A1 publication Critical patent/AR102865A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/635—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/50—Fusion polypeptide containing protease site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21009—Enteropeptidase (3.4.21.9), i.e. enterokinase
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

La presente refiere al campo de la medicina, en particular, a la producción de grandes cantidades de un polipéptido recombinante soluble como parte de una proteína de fusión que comprende una pareja de fusión N-terminal enlazada al polipéptido de interés. Reivindicación 1: Una proteína de fusión recombinante que comprende: una pareja de fusión N-terminal, en donde la pareja de fusión N-terminal es un chaperona bacteriana o un modelador de plegado; un polipéptido de interés; y un enlazador que comprende un sitio de escisión entre la pareja de fusión N-terminal y el polipéptido de interés.
ARP150103916A 2014-12-01 2015-12-01 Parejas de fusión para la producción de péptidos AR102865A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462086119P 2014-12-01 2014-12-01

Publications (1)

Publication Number Publication Date
AR102865A1 true AR102865A1 (es) 2017-03-29

Family

ID=56092296

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP150103916A AR102865A1 (es) 2014-12-01 2015-12-01 Parejas de fusión para la producción de péptidos

Country Status (16)

Country Link
US (2) US10118956B2 (es)
EP (1) EP3227455B1 (es)
JP (2) JP6817939B2 (es)
KR (1) KR102353262B1 (es)
CN (2) CN107532190B (es)
AR (1) AR102865A1 (es)
AU (1) AU2015355242B2 (es)
CA (1) CA2966358C (es)
DK (1) DK3227455T3 (es)
ES (1) ES2952405T3 (es)
MX (1) MX386884B (es)
NZ (1) NZ732400A (es)
RU (1) RU2017123283A (es)
SG (1) SG11201704362VA (es)
TW (1) TWI702289B (es)
WO (1) WO2016089782A1 (es)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2017123283A (ru) 2014-12-01 2019-01-09 Пфенекс Инк. Партнеры по слиянию для получения пептидов
US10289612B2 (en) 2015-05-15 2019-05-14 Foogal Inc. Personal food inventory-based tracking
JP7784804B2 (ja) * 2017-10-27 2025-12-12 フェネックス インク． 組み換えｅｒｗｉｎｉａアスパラギナーゼの製造のための方法
WO2019083794A1 (en) 2017-10-27 2019-05-02 Pfenex Inc. PROCESS FOR PRODUCING EAR ASPARAGINASE. RECOMBINED COLI
WO2019143193A1 (ko) 2018-01-19 2019-07-25 주식회사 펩진 재조합 폴리펩타이드 생산용 n-말단 융합 파트너 및 이를 이용하여 재조합 폴리 펩타이드를 생산하는방법
CN108191981B (zh) * 2018-02-06 2020-11-03 美药星（南京）制药有限公司 一种利拉鲁肽中间体多肽的制备方法
KR102009709B1 (ko) * 2018-02-14 2019-08-12 주식회사 펩진 융합 폴리펩타이드를 이용하여 인간 부갑상선 호르몬 1-84를 생산하는 방법
KR102017540B1 (ko) * 2018-02-14 2019-09-03 주식회사 펩진 융합 폴리펩타이드를 이용하여 글루카곤 유사 펩타이드-1 또는 이의 유사체를 생산하는 방법
KR102017542B1 (ko) * 2018-02-14 2019-09-03 주식회사 펩진 융합 폴리펩타이드를 이용하여 글루카곤 유사 펩타이드-2 또는 이의 유사체를 생산하는 방법
CN108977423A (zh) * 2018-08-17 2018-12-11 集美大学 一种从猪肺中分离提纯血管紧张素转化酶的方法
KR102011291B1 (ko) * 2018-12-05 2019-10-21 주식회사 펩진 신규한 융합 폴리펩타이드 및 이를 이용하여 인간 부갑상선 호르몬 1-34를 생산하는 방법
JP2022514537A (ja) 2018-12-13 2022-02-14 フヤ バイオサイエンス インターナショナル エルエルシー 急性心房細動の処置のためのサルカルディン投与
CN110305223B (zh) * 2019-06-26 2022-05-13 重庆派金生物科技有限公司 重组串联融合蛋白制备目标多肽的方法
KR20210010367A (ko) * 2019-07-19 2021-01-27 주식회사 펩진 인간부갑상선호르몬1-34 생산용 융합태그
KR20210010366A (ko) * 2019-07-19 2021-01-27 주식회사 펩진 글루카곤 유사 펩타이드-1 또는 이의 유사체 생산용 융합태그
KR20210010368A (ko) * 2019-07-19 2021-01-27 주식회사 펩진 글루카곤 유사 펩타이드-2 또는 이의 유사체 생산용 융합태그
US20230032072A1 (en) * 2019-11-08 2023-02-02 Korea Institute Of Ocean Science & Technology Novel human epidermal growth factor-tf fusion protein and use thereof
CN113773400B (zh) * 2020-06-09 2023-08-18 宁波鲲鹏生物科技有限公司 一种门冬胰岛素衍生物及其应用
US20230313154A1 (en) * 2020-07-17 2023-10-05 Cb Therapeutics, Inc. Prenyltransferase enzymes
CN113151296B (zh) * 2021-03-22 2022-09-13 云南中烟工业有限责任公司 一种烟草热激蛋白相关的基因及其应用
CN113025599B (zh) * 2021-04-02 2023-09-12 重庆科润生物医药研发有限公司 一种重组溶组织梭菌i型胶原酶及其制备方法和应用
CN112941058B (zh) * 2021-04-02 2023-12-05 重庆科润生物医药研发有限公司 一种重组溶组织梭菌ii型胶原酶及其制备方法和应用
KR20240021234A (ko) * 2021-06-10 2024-02-16 펠리칸 테크놀로지 홀딩스, 인크. 재조합 단백질 발현을 위한 박테리아 숙주
JP7719946B2 (ja) * 2021-08-06 2025-08-06 エフ． ホフマン－ラ ロシュ アーゲー ＩｇＧアフィニティー精製のためのキメラＩｇＧ－Ｆｃ結合リガンドポリペプチド及びその使用
US20240383959A1 (en) * 2021-09-09 2024-11-21 Northwestern University Cell-free methods and compositions comprising tagless therapeutic hormones
CN114350587B (zh) * 2022-01-24 2023-10-31 修实生物医药(南通)有限公司 一种基因重组串联表达利那洛肽的工程菌
CN115109766A (zh) * 2022-02-14 2022-09-27 上海理工大学 一种耐高温金属蛋白酶及其编码基因和应用
WO2024035782A1 (en) * 2022-08-10 2024-02-15 Aav Gene Therapeutics, Inc. Aav-mediated intramuscular delivery of insulin
WO2025081111A1 (en) * 2023-10-12 2025-04-17 The University Of Chicago Methods and compositions for characterizing rna-binding protein binding sites by in-situ reverse transcription-based sequencing

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769326A (en) 1980-02-29 1988-09-06 The Regents Of The University Of California Expression linkers
US4551433A (en) 1981-05-18 1985-11-05 Genentech, Inc. Microbial hybrid promoters
US4755465A (en) 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
US5281532A (en) 1983-07-27 1994-01-25 Mycogen Corporation Pseudomas hosts transformed with bacillus endotoxin genes
US4695455A (en) 1985-01-22 1987-09-22 Mycogen Corporation Cellular encapsulation of pesticides produced by expression of heterologous genes
US4695462A (en) 1985-06-28 1987-09-22 Mycogen Corporation Cellular encapsulation of biological pesticides
GB8517071D0 (en) 1985-07-05 1985-08-14 Hoffmann La Roche Gram-positive expression control sequence
US5013653A (en) 1987-03-20 1991-05-07 Creative Biomolecules, Inc. Product and process for introduction of a hinge region into a fusion protein to facilitate cleavage
US5128130A (en) 1988-01-22 1992-07-07 Mycogen Corporation Hybrid Bacillus thuringiensis gene, plasmid and transformed Pseudomonas fluorescens
US5055294A (en) 1988-03-03 1991-10-08 Mycogen Corporation Chimeric bacillus thuringiensis crystal protein gene comprising hd-73 and berliner 1715 toxin genes, transformed and expressed in pseudomonas fluorescens
US5169760A (en) 1989-07-27 1992-12-08 Mycogen Corporation Method, vectors, and host cells for the control of expression of heterologous genes from lac operated promoters
US7150974B1 (en) 1991-04-05 2006-12-19 The General Hospital Corporation Parathyroid hormone receptor binding method
WO1993006217A1 (en) 1991-09-19 1993-04-01 Genentech, Inc. EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab')2 ANTIBODIES
CA2125467C (en) 1993-07-06 2001-02-06 Heinz Dobeli Process for producing hydrophobic polypeptides, proteins or peptides
US5935824A (en) 1996-01-31 1999-08-10 Technologene, Inc. Protein expression system
CA2198966C (en) 1996-03-04 2011-06-21 Yuji Suzuki Method for cleaving chimeric protein using processing enzyme
JPH1175879A (ja) * 1997-07-08 1999-03-23 Toyota Central Res & Dev Lab Inc プロテインジスルフィドイソメラーゼを含有する融合タンパク質をコードするｄｎａ
US5989868A (en) 1997-09-12 1999-11-23 The Board Of Regents Of The University Of Oklahoma Fusion protein systems designed to increase soluble cytoplasmic expression of heterologous proteins in esherichia coli
WO1999038984A1 (fr) 1998-01-30 1999-08-05 Suntory Limited Procede de production de peptide au moyen d'un peptide accessoire
US6242219B1 (en) 1999-03-18 2001-06-05 Xoma (Us) Llc Methods for recombinant peptide production
US6906176B2 (en) 2000-06-19 2005-06-14 Dyax Corp. Enterokinase cleavage sequences
JP2002262873A (ja) 2001-03-06 2002-09-17 Inst Of Physical & Chemical Res タンパク質ドメインの製造方法及びその方法により得られたドメインを用いるタンパク質の立体構造解析方法
ES2391623T3 (es) 2001-06-22 2012-11-28 F. Hoffmann-La Roche Ag Complejo soluble que contiene una glicoproteína de superficie retroviral
EP1417237B1 (en) 2001-07-26 2011-04-06 Advanced Protein Technologies Corp. Process for preparation of polypeptides of interest from fusion peolypeptides
AU2003256365B2 (en) 2002-07-03 2010-02-18 Pfenex Inc. Benzoate- and anthranilate-inducible promoters
EP1527181A1 (en) 2002-08-09 2005-05-04 National Research Council Of Canada Staphylococcal nuclease fusion proteins for the production of recombinant peptides
US7208585B2 (en) 2002-09-18 2007-04-24 Genencor International, Inc. Protein purification
US9453251B2 (en) 2002-10-08 2016-09-27 Pfenex Inc. Expression of mammalian proteins in Pseudomonas fluorescens
JPWO2004092221A1 (ja) 2003-04-18 2006-07-06 積水化学工業株式会社 免疫原及び免疫用組成物、並びにそれらを使用する抗体の製造方法
JP2005110591A (ja) 2003-10-08 2005-04-28 Sekisui Chem Co Ltd 蛋白質の分離方法
WO2005052151A1 (en) 2003-11-19 2005-06-09 Dow Global Technologies Inc. Improved protein expression systems
WO2005089093A2 (en) 2003-11-21 2005-09-29 Dow Global Technologies Inc. Improved expression systems with sec-system secretion
WO2005049847A1 (en) 2003-11-24 2005-06-02 Novo Nordisk A/S Fusion proteins and methods of cleavage of such proteins
PL1709170T3 (pl) * 2004-01-16 2018-06-29 Pfenex Inc. Ekspresja białek ssaczych w Pseudomonas fluorescens
WO2006078273A2 (en) * 2004-04-26 2006-07-27 The United States Of America As Represented By Teh Secretary Of Health And Human Services, Nih Methods and compositions for producing recombinant proteins
JP4988337B2 (ja) * 2004-05-21 2012-08-01 タカラバイオ株式会社 ポリペプチドの製造方法
BRPI0513826A2 (pt) * 2004-07-26 2010-06-22 Dow Global Technologies Inc processo para expressão de proteìna melhorada através de engenharia de cepa
WO2006016370A2 (en) 2004-08-11 2006-02-16 Ramot At Tel Aviv University Ltd. Soluble fusion proteins comprising heterologous polypeptides
WO2006126102A2 (en) 2005-04-20 2006-11-30 Viromed Co., Ltd. Compositions and methods for fusion protein separation
AU2006255060B2 (en) 2005-06-06 2012-08-30 Pelican Technology Holdings, Inc. Mannitol induced promoter systems in bacterial host cells
MX2008015213A (es) 2006-05-30 2008-12-09 Dow Global Technologies Inc Metodo de optimizacion de codon.
US8569015B2 (en) 2006-05-30 2013-10-29 Pfenex Inc. RPA optimization
EP1873251A1 (en) * 2006-06-29 2008-01-02 Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus Expression vector(s) for enhanced expression of a protein of interest in eukaryotic or prokaryotic host cells
KR101491867B1 (ko) 2007-01-31 2015-02-10 피페넥스 인크. 증가된 발현을 위한 박테리아 리더 서열
WO2008134461A2 (en) 2007-04-27 2008-11-06 Dow Global Technologies, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
US9580719B2 (en) 2007-04-27 2017-02-28 Pfenex, Inc. Method for rapidly screening microbial hosts to identify certain strains with improved yield and/or quality in the expression of heterologous proteins
MX2010001612A (es) 2007-08-09 2010-07-01 Usv Ltd Novedoso procedimiento ortogonal para la purificacion de la hormona paratiroidea humana recombinante (rhpth) (1-34).
EP2594646A3 (en) * 2007-09-21 2013-11-06 BASF Plant Science GmbH Plant with increased yield
WO2009086132A2 (en) 2007-12-20 2009-07-09 University Of Southern California Design of spacers to increase the expression of recombinant fusion proteins
EP2127678A1 (en) 2008-05-26 2009-12-02 Roche Diagnostics GmbH SlpA as a tool for recombinant protein and enzyme technology
JP2010006745A (ja) * 2008-06-27 2010-01-14 Sekisui Chem Co Ltd 融合タンパク質、融合タンパク質固定化担体、化合物のスクリーニング方法、スクリーニング用組成物、並びに、スクリーニング用キット
WO2010064748A1 (en) 2008-12-04 2010-06-10 Korea Research Institute Of Bioscience And Biotechnology Screening of abundantly secreted proteins and their use as fusion partners for the production of recombinant proteins
PL2552949T3 (pl) 2010-04-01 2017-01-31 Pfenex Inc. Sposoby wytwarzania G-CSF w komórce gospodarza Pseudomonas
WO2011151714A1 (en) 2010-06-04 2011-12-08 Lupin Limited Modified sak gene for the production of recombinant proteins
AR086250A1 (es) 2011-05-05 2013-11-27 Hoffmann La Roche Polipeptido de fusion presentador de una secuencia de aminoacidos y utilizacion del mismo
US9169304B2 (en) 2012-05-01 2015-10-27 Pfenex Inc. Process for purifying recombinant Plasmodium falciparum circumsporozoite protein
RU2017123283A (ru) 2014-12-01 2019-01-09 Пфенекс Инк. Партнеры по слиянию для получения пептидов
WO2016129637A1 (ja) 2015-02-13 2016-08-18 積水化学工業株式会社 核酸、融合タンパク質、組換え細胞、並びに、イソプレン又は環式テルペンの生産方法

Also Published As

Publication number Publication date
CN113444183B (zh) 2025-06-17
JP2017536835A (ja) 2017-12-14
CN107532190B (zh) 2021-07-09
MX2017006866A (es) 2017-11-15
CA2966358C (en) 2021-12-07
US10118956B2 (en) 2018-11-06
US20190135889A1 (en) 2019-05-09
AU2015355242A1 (en) 2017-06-22
NZ732400A (en) 2021-07-30
TW201629226A (zh) 2016-08-16
EP3227455B1 (en) 2023-07-12
CN107532190A (zh) 2018-01-02
KR20170085129A (ko) 2017-07-21
JP7148579B2 (ja) 2022-10-05
KR102353262B1 (ko) 2022-01-18
JP2021003117A (ja) 2021-01-14
HK1245336A1 (en) 2018-08-24
CN113444183A (zh) 2021-09-28
WO2016089782A1 (en) 2016-06-09
RU2017123283A (ru) 2019-01-09
DK3227455T3 (da) 2023-08-21
AU2015355242B2 (en) 2020-10-08
MX386884B (es) 2025-03-19
ES2952405T3 (es) 2023-10-31
US10981968B2 (en) 2021-04-20
EP3227455A4 (en) 2018-07-04
JP6817939B2 (ja) 2021-01-20
TWI702289B (zh) 2020-08-21
SG11201704362VA (en) 2017-06-29
CA2966358A1 (en) 2016-06-09
US20160159877A1 (en) 2016-06-09
BR112017011662A2 (pt) 2018-02-27
EP3227455A1 (en) 2017-10-11

Similar Documents

Publication Publication Date Title
AR102865A1 (es) Parejas de fusión para la producción de péptidos
CY1122701T1 (el) Απελευθερωση πρωτεϊνης με βαση βακτηρια
CL2019001000A1 (es) Proteínas de fusión fc heterodiméricas il15/il15ralfa
CL2018000232A1 (es) Mezcla de péptidos (divisional solicitud 201601405)
MX2016011580A (es) Dominios de fibronectina tipo iii que se unen a albumina de suero.
EA201790895A1 (ru) Модифицированные полипептиды fgf-21 и их применение
HK1249048A1 (zh) 靶向afp肽/mhc复合体的构建体及其用途
UY37970A (es) Plataforma de presentación, productos y métodos con endosporas basadas en paenibacillus
TW201613958A (en) MIC-1 fusion proteins and uses thereof
HK1222662A1 (zh) 体外生产具有可分选蛋白的无核红细胞
CY1123654T1 (el) Αποδεσμευση πρωτεϊνης me βαση βακτηρια
WO2016210365A3 (en) Constructs targeting ny-eso-1 peptide/mhc complexes and uses thereof
ES2676499T3 (es) Proteínas de fusión Fc que comprenden nuevos enlazadores o disposiciones
CL2011003003A1 (es) Composicion tensioactiva reconstituida que comprende un polipeptido análogo a la proteína surfactante c nativa, un polipeptido análogo a la proteína surfactante b nativa, un fosfolipido monoinsaturado y un fosfolipido saturado, útil para el tratamiento del síndrome de dificultad respiratoria.
CY1119149T1 (el) Αντικαρκινικη πρωτεϊνη συντηξης
CR20180509A (es) Contorsbody - un ligante de diana monocatenario
CY1124727T1 (el) Πρωτεϊνες συντηξης tatk-cdkl5, συνθεσεις, φαρμακοτεχνικες μορφες και η χρηση αυτων
MX2021012047A (es) Polipeptidos de fusion de serpina y metodos para utilizar los mismos.
MX2017000332A (es) Sistema de expresion bacterial bicistronico.
MX2016002539A (es) Constructo de fusion de la fraccion efectora del fragmento de union a antigeno (fab) de anti-albumina de suero y su metodo de preparacion.
WO2015187992A3 (en) Map44 polypeptides and constructs based on natural antibodies and uses thereof
MX2018003445A (es) Expresion de proteinas que contienen fc.
BR112015023738B8 (pt) Vacinas de nucleoproteina influenza
MX2017008406A (es) Conjugados de aminoacidos y peptidos y sus usos.
CL2016003317A1 (es) Anticuerpos biespecificos anti-il4-il13

Legal Events

Date Code Title Description
FB Suspension of granting procedure